RISPERDAL related Press Releases
Alkermes Announces Shareholder Vote in Favor of Merger with Elan Drug Technologies
– 99.9% of Votes Cast Were in Favor of Merger – – Transaction Expected to Close on Sept. 16, 2011 – WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) today announced that Alkermes Read more...
Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2012
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. ET on Monday, August 1, 2011, to discuss the company’s financial results for the first quarter Read more...
Alkermes to Webcast Analyst and Investor Day
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) today announced that it will webcast its Analyst and Investor Day being held on Monday, July 18, 2011, at the Boston Harbor Hotel. The Read more...
Alkermes' Corporate Presentation to be Webcast at the NASDAQ OMX 26th Investor Program
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the NASDAQ OMX 26th Investor Program on Tuesday, June 21, 2011, Read more...
Alkermes’ Corporate Presentation to Be Webcast at Two Upcoming Conferences
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live from the Jefferies 2011 Global Healthcare Conference on Monday, Read more...
Alkermes’ Corporate Presentation to be Webcast at the UBS Global Specialty Pharmaceuticals Conference
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the UBS Global Specialty Pharmaceuticals Conference on Tuesday, Read more...
Alkermes to Host Conference Call to Discuss Fiscal Year 2011 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. ET on Wednesday, May 18, 2011, to discuss the company’s financial results for fiscal year Read more...
Alkermes’ Corporate Presentation to Be Webcast at the Cowen Health Care Conference
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen 31st Annual Health Care Conference on Monday, March Read more...
Alkermes’ Corporate Presentation to be Webcast at the BIO CEO & Investor Conference
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the BIO CEO & Investor Conference on Tuesday, February 15, Read more...
Alkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2011
WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. ET on Thursday, February 3, 2011, to discuss the company’s financial results for the third Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
